Zymergen is a biotechnology company based in Emeryville, CA, specializing in the development of innovative biological engineering solutions. With a focus on biopharmaceuticals, industrial biotechnology, and agriculture, Zymergen offers a wide range of services and products, including RNA services, gene therapy services, enzymes, proteins, natural products, fermentation scale-up, and ag biologicals. The company's platform integrates automation and software capabilities, allowing for the optimization and design of various biological concepts.
Ginkgo, a leading biotechnology company, recently completed the acquisition of Zymergen, marking a significant milestone in their long-term growth. The merger is expected to enhance Ginkgo's platform by incorporating Zymergen's expertise in diverse biological engineering approaches and strong automation and software capabilities. With the integration of Zymergen's capabilities, Ginkgo aims to explore new partnerships and opportunities for the development of their diverse array of product concepts. The acquisition involved Zymergen stockholders receiving Ginkgo Class A common stock, and Zymergen shares will no longer be traded on Nasdaq.
Generated from the website